SEARCH

MEDIA

CAREERS

CONTACT

Nektar
  • Our Company
    • Our Story
    • Our Leadership
    • Our Board of Directors
    • Our Partners
    • Locations
    • Contact
  • Our Pipeline
    • R&D Pipeline
      • Onzeald® (etirinotecan pegol)
      • Bempegaldesleukin (NKTR-214)
      • Dapirolizumab Pegol (Anti-CD40L)
      • NKTR-358
      • NKTR-262
      • NKTR-255
    • Clinical Trials
    • Expanded Access
    • Investigator Sponsored Research
  • Our Medicines
    • U.S. Medicines Marketed by Our Partners
    • EU Medicines Marketed by Our Partners
    • Investigational Medicines
  • Our Science
    • Research Platform
    • Scientific & Clinical Data Presentations
    • Scientific & Medical Events
  • Investors
    • About Us
    • Press Releases
    • Investor Events
    • Stock Information
      • Historic Stock Lookup
    • Analyst Coverage
    • Financials & Filings
      • SEC Filings
      • Annuals and Proxies
      • Quarterly Results
    • Corporate Governance
    • Investor Contacts
    • E-mails Alerts
  • Media
    • Media Room
    • Video Gallery
    • Image Gallery
  • Careers
    • Life at Nektar
    • Search Jobs
    • Search Jobs (Mobile Device)
    • Benefits at Nektar
      • Benefits at San Francisco, California
      • Benefits at Huntsville, Alabama
      • Benefits at Hyderabad, India
    • Information for Recruiters

Nektar

QUICK LINKS

Our Company

Our Pipeline

Our Medicines

Our Science

Investors

Media

Careers

Contact

Privacy

Terms of Use

CONNECT

LOCATIONS

San Francisco, CA

San Francisco Office

Huntsville, AL

Alabama Office

Hyderabad, India

Hyberabad, India
Copyright Nektar © 2020